Pachychoroid disease: review and update

被引:8
作者
Cheung, Chui Ming Gemmy [1 ,2 ,3 ]
Dansingani, Kunal K. [4 ]
Koizumi, Hideki [5 ]
Lai, Timothy Y. Y. [6 ]
Sivaprasad, Sobha [7 ]
Boon, Camiel J. F. [8 ,9 ]
Van Dijk, Elon H. C. [9 ]
Chhablani, Jay [4 ]
Lee, Won Ki [10 ]
Freund, K. Bailey [11 ,12 ]
机构
[1] Singapore Natl Eye Ctr, Singapore, Singapore
[2] Singapore Eye Res Inst, Singapore, Singapore
[3] Duke NUS Med Sch, Singapore, Singapore
[4] Univ Pittsburgh, Med Ctr, Dept Ophthalmol, Pittsburgh, PA USA
[5] Univ Ryukyus, Grad Sch Med, Dept Ophthalmol, Okinawa, Japan
[6] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Peoples R China
[7] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, Moorfields Clin Res Facil, London, England
[8] Amsterdam Univ Med Ctr, Amsterdam, Netherlands
[9] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands
[10] Nune Eye Hosp, Seoul, South Korea
[11] Vitreous Retina Macula Consultants New York, New York, NY USA
[12] NYU, Grossman Sch Med, Dept Ophthalmol, New York, NY USA
来源
基金
英国医学研究理事会;
关键词
POLYPOIDAL CHOROIDAL VASCULOPATHY; CENTRAL SEROUS CHORIORETINOPATHY; OPTICAL COHERENCE TOMOGRAPHY; VERTEPORFIN PHOTODYNAMIC THERAPY; INDOCYANINE GREEN ANGIOGRAPHY; MACULAR DEGENERATION; CLINICAL CHARACTERISTICS; SCLERAL THICKNESS; MICROPULSE LASER; VORTEX VEIN;
D O I
10.1038/s41433-024-03253-4
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The pachychoroid disease spectrum is a phenotype characterized by alterations in choroidal vasculature which result in outer retinal and choriocapillaris damage and visual loss. The presence of pachyvessels is one of the key features of the pachychoroid phenotype. Recent imaging studies suggest that pachyvessels may form because of choroidal venous congestion in one or more quadrants. The formation of intervortex anastomosis may function as a compensatory mechanism to dissipate the increased venous pressure, while outflow obstruction has been hypothesized to occur at the site of the vortex vein exiting the sclera. This review aims to summarize recent imaging findings and discuss evolution in the understanding of pathogenesis of the pachychoroid disease spectrum. We have summarized notable treatment trials in central serous chorioretinopathy and polypoidal choroidal vasculopathy and included an update of the current diagnostic and management strategies of the entities that are part of the pachychoroid disease spectrum.
引用
收藏
页码:819 / 834
页数:16
相关论文
共 147 条
  • [51] Variation of vortex veins at the horizontal watershed in normal eyes
    Hoshino, Junki
    Matsumoto, Hidetaka
    Mukai, Ryo
    Nakamura, Kosuke
    Arai, Yosuke
    Kikuchi, Yuka
    Kishi, Shoji
    Akiyama, Hideo
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 259 (08) : 2175 - 2180
  • [52] Hubschman Sasha, 2022, Am J Ophthalmol Case Rep, V25, P101338, DOI 10.1016/j.ajoc.2022.101338
  • [53] ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY OF THE CHOROID IN CENTRAL SEROUS CHORIORETINOPATHY
    Imamura, Yutaka
    Fujiwara, Takamitsu
    Margolis, Ron
    Spaide, Richard F.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (10): : 1469 - 1473
  • [54] Relationship Between Scleral Thickness and Choroidal Structure in Central Serous Chorioretinopathy
    Imanaga, Naoya
    Terao, Nobuhiro
    Sonoda, Shozo
    Sawaguchi, Shota
    Yamauchi, Yukihide
    Sakamoto, Taiji
    Koizumi, Hideki
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (01)
  • [55] Scleral Thickness in Central Serous Chorioretinopathy
    Imanaga, Naoya
    Terao, Nobuhiro
    Nakamine, Sakari
    Tamashiro, Tamaki
    Wakugawa, Sorako
    Sawaguchi, Keiko
    Koizumi, Hideki
    [J]. OPHTHALMOLOGY RETINA, 2021, 5 (03): : 285 - 291
  • [56] Photodynamic therapy as a treatment option for peripapillary pachychoroid syndrome: a pilot study
    Iovino, Claudio
    Peiretti, Enrico
    Tatti, Filippo
    Querques, Giuseppe
    Borrelli, Enrico
    Sacconi, Riccardo
    Chhablani, Jay
    Agrawal, Hitesh
    Boon, Camiel J. F.
    van Dijk, Elon H. C.
    Cennamo, Gilda
    Lupidi, Marco
    Muzi, Alessio
    Di Iorio, Valentina
    Iglicki, Matias
    Smadar, Lital
    Loewenstein, Anat
    Zur, Dinah
    [J]. EYE, 2022, 36 (04) : 716 - 723
  • [57] One-year outcomes of intravitreal brolucizumab injections in patients with polypoidal choroidal vasculopathy
    Ito, Arisa
    Maruyama-Inoue, Maiko
    Kitajima, Yoko
    Ikeda, Shoko
    Inoue, Tatsuya
    Kadonosono, Kazuaki
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [58] Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
    Jung, Byung Ju
    Kim, JooYoung
    Lee, Jae Hyung
    Baek, Jiwon
    Lee, Kook
    Lee, Won Ki
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [59] Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities
    Kaye, Rebecca
    Chandra, Shruti
    Sheth, Jay
    Boon, Camiel J. F.
    Sivaprasad, Sobha
    Lotery, Andrew
    [J]. PROGRESS IN RETINAL AND EYE RESEARCH, 2020, 79
  • [60] Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy
    Khandhadia, Samir
    Thulasidharan, Suresh
    Hoang, Nguyen Thuy Vy
    Ibrahim, Sameh Alkhalili
    Ouyang, Yanling
    Lotery, Andrew
    [J]. EYE, 2023, 37 (12) : 2548 - 2553